|
Volumn 2, Issue 10, 2012, Pages
|
Trial is halted for ganitumab in pancreatic cancer
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIGITUMUMAB;
GANITUMAB;
GEMCITABINE;
GROWTH HORMONE;
SOMATOMEDIN C RECEPTOR;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER INHIBITION;
DRUG TARGETING;
HUMAN;
LUNG NON SMALL CELL CANCER;
NOTE;
OVERALL SURVIVAL;
PANCREAS METASTASIS;
PHASE 3 CLINICAL TRIAL (TOPIC);
TREATMENT OUTCOME;
|
EID: 84868021828
PISSN: 21598274
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2012-100 Document Type: Note |
Times cited : (2)
|
References (0)
|